A design for phase I trials in completely or partially ordered groups.

Abstract excerpt

We propose a design for dose finding for cytotoxic agents in completely or partially ordered groups of patients. By completely ordered groups, we mean that prior to the study, there is clinical information that would indicate that for a given dose, the groups can be ordered with respect to the probability of toxicity at that dose. With partially ordered groups, at a given dose, only some of the groups can be...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biostatistics
• Share to Clinical Trials, Phase I as Topic
• Share to Cytotoxins